Education
About Us
Working with TipRanks
Follow Us
Saniona AB (DE:30S)
FRANKFURT:30S
30S Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.12 - €0.82
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€79.28M
Enterprise Value€621.06M
Total Cash (Recent Filing)kr71.44M
Total Debt (Recent Filing)kr66.76M
Price to Earnings (P/E)3.7
Beta0.35
Next Earnings
May 21, 2025EPS EstimateN/A
Last Dividend Ex-Date
Oct 20, 2016Dividend YieldN/A
Share Statistics
EPS (TTM)0.14
Shares Outstanding135,521,840
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)30.61
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
30S FAQ
What was Saniona AB’s price range in the past 12 months?
Saniona AB lowest stock price was €0.12 and its highest was €0.82 in the past 12 months.
What is Saniona AB’s market cap?
Saniona AB’s market cap is €79.28M.
When is Saniona AB’s upcoming earnings report date?
Saniona AB’s upcoming earnings report date is May 21, 2025 which is in 29 days.
How were Saniona AB’s earnings last quarter?
Saniona AB released its earnings results on Feb 27, 2025. The company reported €0.202 earnings per share for the quarter, beating the consensus estimate of N/A by €0.202.
Is Saniona AB overvalued?
According to Wall Street analysts Saniona AB’s price is currently Overvalued.
Does Saniona AB pay dividends?
Saniona AB pays a Notavailable dividend of €0.009 which represents an annual dividend yield of N/A. See more information on Saniona AB dividends here
What is Saniona AB’s EPS estimate?
Saniona AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Saniona AB have?
Saniona AB has 135,521,840 shares outstanding.
What happened to Saniona AB’s price movement after its last earnings report?
Saniona AB reported an EPS of €0.202 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.449%.
Which hedge fund is a major shareholder of Saniona AB?
Currently, no hedge funds are holding shares in DE:30S
---
Company Description
Saniona AB
Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases and the treatment of pain. It develops a technology platform that enables the investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. The company product pipeline includes Tesomet, SAN711, Tesofensine, NS2359, and CAD-1883.
---
Technical Analysis
SynAct Pharma AB
―
Xbrane Biopharma AB
―
IRLAB Therapeutics AB Class A
―
Guard Therapeutics International AB
―
Xspray Pharma AB
―
---